TipRanks
PTC Therapeutics (PTCT)
NASDAQ:PTCT
US Market
Want to see PTCT full AI Analyst Report?

PTC Therapeutics (PTCT) Revenue by Segment

433 Followers

Revenue by Segment

Breaks down revenue by different business segments, indicating which areas are most profitable and where the company might focus future efforts.
Royalties are the cleanest, steadily expanding base and look like the most reliable long‑term growth driver, while Net Product remains the bulk of recurring revenue with cyclical quarters but an overall recovery to new highs—a sign of durable product demand. By contrast, Collaboration and Manufacturing are wildly lumpy (large one‑off spikes and even a big negative adjustment), so treat those as non‑recurring noise when modeling earnings or valuing the company; focus on royalties and net product for sustainable cash‑flow visibility.
Date
Manufacturing
Collaboration
Royalty
Net Product
Jun 30, 2026
$0.00$50.59M$71.11M$238.82M
Mar 31, 2026
$0.00$143.00K$46.84M$225.57M
Dec 31, 2025
-$98.63M-$73.00K$79.39M$183.99M
Sep 30, 2025
$0.00$9.26M$70.79M$130.96M
Jun 30, 2025
$0.00$2.94M$57.60M$118.33M
Mar 31, 2025
$0.00$986.23M$36.44M$153.43M
Dec 31, 2024
$0.00$304.00K$58.16M$154.71M
Sep 30, 2024
$0.00$0.00$61.37M$135.42M
Jun 30, 2024
$301.00K$0.00$53.18M$133.22M
Mar 31, 2024
$1.36M$0.00$31.15M$177.60M